Rabies vaccine preserved by vaporization is thermostable and immunogenic
Authors:
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R44AI080035)
- Oak Ridge Institute for Science and Education
- U.S. Department of Energy
- CDC
This publication has 16 references indexed in Scilit:
- Current and future tools for global canine rabies eliminationAntiviral Research, 2013
- Host–rabies virus protein–protein interactions as druggable antiviral targetsProceedings of the National Academy of Sciences, 2013
- Lagos Bat Virus in KenyaJournal of Clinical Microbiology, 2008
- Drying-Induced Variations in Physico-Chemical Properties of Amorphous Pharmaceuticals and Their Impact on Stability (I): Stability of a Monoclonal Antibody *Journal of Pharmaceutical Sciences, 2007
- The rabies peripheral challenge test: More accurate determination of vaccine potencyVaccine, 2006
- Both Viral Transcription and Replication Are Reduced when the Rabies Virus Nucleoprotein Is Not PhosphorylatedJournal of Virology, 2002
- Use of a vaccinia-rabies recombinant virus for the oral vaccination of foxes against rabiesVaccine, 1990
- Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus.Proceedings of the National Academy of Sciences, 1983
- A rapid reproducible test for determining rabies neutralizing antibody.1973
- An Attenuated Rabies Vaccine for Domestic Animals Produced in Tissue Culture.1964